AzTrials
AzTrials

Superior Oblique Muscle PalsyEXCYCLOTORSIONNCT02894411

Routine Care Study Evaluating Ocular Torsion

An observational study of Superior Oblique Muscle Palsy, run by Fondation Ophtalmologique Adolphe de Rothschild at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The paralysis of the fourth cranial nerve (paralysis IV), commonly known as the superior oblique muscle (SO) paralysis, represents half of vertical strabismus. The diagnosis of SO paralysis and of its congenital or acquired etiology, are based on a range of clinical findings. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Superior Oblique Muscle Palsy
How many people
172 participants
Where
1 siteFrance
Study dates
21 Dec 2016to 20 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with SO muscle unilateral paralysis and patients without oculomotor disorder, matched for age.

Who may be able to join

  • For the subjects without oculomotor disorder
  • no diplopia in different positions of gaze;
  • no oculomotor disorder during the orthoptic examination (horizontal phoria <8 prism diopter, vertical phoria <4 prism diopter);
  • corrected visual acuity > 8/10 on both eyes;
  • binocular vision present in Lang I test (defined by 3 elements seen or appointed);
  • orbital MRI: normal oculomotor muscles (including absence of atrophy of the superior oblique muscle) and lack of intra orbital expansive process;
Show all 11Show fewer
  • brain MRI: no abnormalities in the ways of oculomotor (especially no abnormalities in posterior fossa).
  • For the patients with SO muscle unilateral paralysis
  • clinical features compatible with unilateral paralysis of the SO muscle
  • muscular body atrophy of the SO on the orbital MRI without other orbital or cerebral abnormality
  • binocular vision in Lang I test

Who cannot join

  • high refractive error (< -6 diopter or >6 diopter);
  • history or current oculomotor disorder or restrictive neurological disorder (dysthyroid orbitopathy, orbital trauma, retinal detachment surgery, paralysis oculomotor palsy other than IV);
  • optic nerve head abnormalities in the fundus (edema for example)
  • lack of binocular vision Lang I test;
  • pregnant or breastfeeding patient
  • patient under legal protection
  • patient opposition to participate in the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • Fondation Ophtalmologique A de Rothschild

    Paris, 75019

Other trials in France

About this study

The paralysis of the fourth cranial nerve (paralysis IV), commonly known as the superior oblique muscle (SO) paralysis, represents half of vertical strabismus. The diagnosis of SO paralysis and of its congenital or acquired etiology, are based on a range of clinical findings. The three main clinical diagnostic elements are the hypertropia in paralyzed side which increases in adducted position, the positivity of Bielschowsky head tilt test and the twisting of the eye fundus. These criteria are always considered together and are interdependent. The diagnostic value and the sensitivity of each of these signs is not defined. Brain and orbital Magnetic Resonance Imaging (MRI) allowed a better understanding of the physiopathology of a number of oculomotor disorders.

For this reason, MRI constitute a reference for the SO palsy. The atrophy of the SO muscle is qualitatively determined by the asymmetry of muscle volume on two contiguous coronal MRI.

The diagnostic value of various clinical signs observed in SO paralysis (sensitivity, specificity) remains unknown.

Keywords
MRI, Excyclotorsion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02894411
Study groupRoleWhat they receive
No ocular motility disordersPatients without ocular motility disorders, with normal orbital and brain MRI.
superior oblique muscle palsyClinical features compatible with unilateral paralysis of the SO muscle Atrophy of the SO muscle on the orbital MRI without other orbital or cerebral anomaly

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. objective ocular torsion

    The angle of objective ocular torsion is measured on a photography of the eye fundus.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2016 (estimated)
  2. Study start21 Dec 2016
  3. Primary completion24 Oct 2019
  4. Study completion20 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
172 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02894411
Sponsor's protocol ID
VTN_2016_18
Acronym
EXCYCLOTORSION
Status last verified
Jan 2020
First submitted
5 Sep 2016
Last updated
22 Jan 2020
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Superior Oblique Muscle Palsy, run by Fondation Ophtalmologique Adolphe de Rothschild at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

objective ocular torsion (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in